Peter S. Bergin

806 total citations
23 papers, 562 citations indexed

About

Peter S. Bergin is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Genetics. According to data from OpenAlex, Peter S. Bergin has authored 23 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 6 papers in Pediatrics, Perinatology and Child Health and 5 papers in Genetics. Recurrent topics in Peter S. Bergin's work include Epilepsy research and treatment (10 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Genomics and Rare Diseases (3 papers). Peter S. Bergin is often cited by papers focused on Epilepsy research and treatment (10 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Genomics and Rare Diseases (3 papers). Peter S. Bergin collaborates with scholars based in New Zealand, Australia and Italy. Peter S. Bergin's co-authors include D. R. Fish, Simon Shorvon, Frédérick Andermann, François Dubeau, Fernando Cendes, Craig Watson, Mark Cook, S. L. Free, Douglas L. Arnold and Richard L. M. Faull and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Brain.

In The Last Decade

Peter S. Bergin

21 papers receiving 548 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter S. Bergin New Zealand 10 225 206 146 108 99 23 562
Linda Franic United States 6 163 0.7× 176 0.9× 102 0.7× 172 1.6× 157 1.6× 10 546
Lilyana Angelov United States 7 154 0.7× 165 0.8× 91 0.6× 168 1.6× 195 2.0× 11 748
Güzide Turanlı Türkiye 15 367 1.6× 111 0.5× 269 1.8× 63 0.6× 111 1.1× 51 736
S. Binelli Italy 20 387 1.7× 185 0.9× 260 1.8× 124 1.1× 209 2.1× 43 926
Elena Pasini Italy 18 162 0.7× 118 0.6× 63 0.4× 45 0.4× 154 1.6× 53 842
Donatella Tampieri Canada 14 162 0.7× 166 0.8× 82 0.6× 29 0.3× 150 1.5× 35 700
Yongzhi Shan China 13 229 1.0× 124 0.6× 87 0.6× 37 0.3× 72 0.7× 86 518
Dilek Yalnızoğlu Türkiye 17 350 1.6× 192 0.9× 267 1.8× 178 1.6× 200 2.0× 72 1.0k
Eric Schmedding Belgium 14 93 0.4× 359 1.7× 70 0.5× 108 1.0× 264 2.7× 33 827
Olaf Schijns Netherlands 16 300 1.3× 251 1.2× 156 1.1× 71 0.7× 146 1.5× 75 908

Countries citing papers authored by Peter S. Bergin

Since Specialization
Citations

This map shows the geographic impact of Peter S. Bergin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter S. Bergin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter S. Bergin more than expected).

Fields of papers citing papers by Peter S. Bergin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter S. Bergin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter S. Bergin. The network helps show where Peter S. Bergin may publish in the future.

Co-authorship network of co-authors of Peter S. Bergin

This figure shows the co-authorship network connecting the top 25 collaborators of Peter S. Bergin. A scholar is included among the top collaborators of Peter S. Bergin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter S. Bergin. Peter S. Bergin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bergin, Peter S., Ettore Beghi, Lynette G. Sadleir, et al.. (2017). Do neurologists around the world agree when diagnosing epilepsy? – Results of an international EpiNet study. Epilepsy Research. 139. 43–50. 4 indexed citations
2.
Rustenhoven, Justin, Thomas Park, Patrick Schweder, et al.. (2016). Isolation of highly enriched primary human microglia for functional studies. Scientific Reports. 6(1). 19371–19371. 67 indexed citations
3.
Bergin, Peter S., Ettore Beghi, Wendyl D’Souza, et al.. (2015). The EpiNet Collaboration: Do Neurologists Around the World Agree when Diagnosing Epilepsy? - Results of a Multinational Study. (S14.004). Neurology. 84(14_supplement). 1 indexed citations
4.
Rustenhoven, Justin, Emma L. Scotter, Deidre Jansson, et al.. (2015). An anti-inflammatory role for C/EBPδ in human brain pericytes. Scientific Reports. 5(1). 12132–12132. 46 indexed citations
5.
Jost, Jérémy, Voa Ratsimbazafy, Pierre‐Marie Preux, et al.. (2015). Epilepsy management and clinical research could be improved in low and middle income countries (LMICs) by epinet database. Journal of the Neurological Sciences. 357. e24–e24. 1 indexed citations
6.
Wu, Teddy Y., Jennifer M. Taylor, Dean H. Kilfoyle, et al.. (2014). Autonomic dysfunction is a major feature of cerebellar ataxia, neuropathy, vestibular areflexia 'CANVAS' syndrome. Brain. 137(10). 2649–2656. 57 indexed citations
7.
Bergin, Peter S., Lynette G. Sadleir, Benjamin Legros, et al.. (2012). An international pilot study of an internet‐based platform to facilitate clinical research in epilepsy: The EpiNet project. Epilepsia. 53(10). 1829–1835. 10 indexed citations
8.
Pereira, Jennifer, et al.. (2011). Medically refractory neurosarcoidosis treated with infliximab. Internal Medicine Journal. 41(4). 354–357. 29 indexed citations
9.
Hill, Andrew, Peter S. Bergin, Paul Thompson, et al.. (2010). Detecting acute neurotoxicity during platinum chemotherapy by neurophysiological assessment of motor nerve hyperexcitability. BMC Cancer. 10(1). 451–451. 42 indexed citations
10.
Bergin, Peter S., Ettore Beghi, & John U. Egbuji. (2010). The EpiNet project—Invitation to participate in investigator‐led clinical research. Epilepsia. 51(9). 1919–1920. 1 indexed citations
11.
Bergin, Peter S., Tony Ip, Robert Sheehan, et al.. (2009). Using the Internet to recruit patients for epilepsy trials: Results of a New Zealand pilot study. Epilepsia. 51(5). 868–873. 6 indexed citations
12.
Kleinig, Timothy, et al.. (2008). MRI of sporadic Creutzfeldt–Jakob disease. Journal of Medical Imaging and Radiation Oncology. 52(4). 318–324. 5 indexed citations
13.
Bergin, Peter S., Lynette G. Sadleir, & Elizabeth Walker. (2008). Bringing epilepsy out of the shadows in New Zealand.. PubMed. 121(1268). U2894–U2894. 4 indexed citations
14.
Bergin, Peter S., Richard Frith, Elizabeth Walker, et al.. (2007). NEXT MONTH IN Epilepsia. Epilepsia. 48(7). 1425–1426. 1 indexed citations
15.
Mee, Edward, et al.. (2007). Adult Neurogenesis in Mesial Temporal Lobe Epilepsy: A Review of Recent Animal and Human Studies. Current Pharmaceutical Biotechnology. 8(3). 187–194. 15 indexed citations
16.
Ng, Jennifer, James Cleland, & Peter S. Bergin. (2003). Retinal detachmen. The Lancet. 362(9384). 639–639.
17.
Langham, Robyn G., Peter S. Bergin, David M. Kaye, et al.. (1999). Quantitative analysis of PDGFA, PDGFB, PDGF receptor β and TGF-β1 mRNA in cardiac transplant biopsies. Transplantation Proceedings. 31(1-2). 131–132. 3 indexed citations
18.
Bergin, Peter S., D. R. Fish, Simon Shorvon, et al.. (1995). Magnetic resonance imaging in partial epilepsy: additional abnormalities shown with the fluid attenuated inversion recovery (FLAIR) pulse sequence.. Journal of Neurology Neurosurgery & Psychiatry. 58(4). 439–443. 63 indexed citations
19.
Cendes, Fernando, Mark Cook, Craig Watson, et al.. (1995). Frequency and characteristics of dual pathology in patients with lesional epilepsy. Neurology. 45(11). 2058–2064. 190 indexed citations
20.
Bergin, Peter S., David H. Miller, Nicholas Hirsch, & N.M.F. Murray. (1993). Failure of 3,4‐diaminopyridine to reverse conduction block in inflammatory demyelinating neuropathies. Annals of Neurology. 34(3). 406–409. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linda Franic Breakdown of academic impact, for papers by Lilyana Angelov Breakdown of academic impact, for papers by Güzide Turanlı Breakdown of academic impact, for papers by S. Binelli Breakdown of academic impact, for papers by Elena Pasini Breakdown of academic impact, for papers by Donatella Tampieri Breakdown of academic impact, for papers by Yongzhi Shan Breakdown of academic impact, for papers by Dilek Yalnızoğlu Breakdown of academic impact, for papers by Eric Schmedding Breakdown of academic impact, for papers by Olaf Schijns
Rankless by CCL
2026